GSK232
potent, selective CECR2 bromodomain inh. cell permeable tool compound from HTS + SBDD on ATAD2, CECR2 model J. Med. Chem., May 28, 2020 GlaxoSmithKline, Stevenage, UK
Molecules of the Month - May 2020
Molecules of the Month
- eFT226 (zotatifin)
- DS-1971a
- BMS-986235/LAR-1219
- JNJ-54717793
- “compound 34”
- GNE-149
- [18F]LSN3316612
- RO7185876
- ONO-8430506
- "compound 15"
- NLG802
- “compound 6g”
- GSK232
- LEI401